EUR 0.06
(-5.84%)
Year | Eps | Eps Growth |
---|---|---|
2022 | -0.00 EUR | 100.0% |
2021 | -10.41 Thousand EUR | -37.21% |
2020 | -7587.51 EUR | 87.63% |
2019 | -61.31 Thousand EUR | -137320.84% |
2018 | -44.62 EUR | 68.78% |
2017 | -142.93 EUR | 22.73% |
2016 | -184.97 EUR | 18.0% |
2015 | -225.57 EUR | -50.8% |
2014 | -149.58 EUR | 99.88% |
2013 | -127.72 Thousand EUR | 4.72% |
2012 | -134.04 Thousand EUR | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2023 Q2 | - EUR | 0.0% |
2022 Q4 | -8.01 EUR | 0.0% |
2022 Q2 | -1936.75 EUR | 0.0% |
2022 FY | - EUR | 98.86% |
2021 Q4 | -164.65 EUR | 0.0% |
2021 Q2 | -3201.09 EUR | 0.0% |
2021 FY | - EUR | -37.21% |
2020 Q2 | -9602.41 EUR | 0.0% |
2020 FY | - EUR | 87.63% |
2020 Q4 | -522.64 EUR | 0.0% |
2019 Q4 | -12.85 Thousand EUR | 0.0% |
2019 FY | - EUR | -137320.84% |
2019 Q2 | -48.46 Thousand EUR | 0.0% |
2018 Q2 | - EUR | 0.0% |
2018 FY | - EUR | 68.78% |
2018 Q4 | - EUR | 0.0% |
2017 Q4 | - EUR | 0.0% |
2017 FY | - EUR | 22.73% |
2017 Q2 | - EUR | 0.0% |
2016 Q4 | - EUR | 0.0% |
2016 FY | - EUR | 18.0% |
2016 Q2 | - EUR | 0.0% |
2015 FY | - EUR | -50.8% |
2015 Q2 | - EUR | 0.0% |
2015 Q4 | - EUR | 0.0% |
2014 FY | - EUR | 99.88% |
2014 Q4 | - EUR | 0.0% |
2014 Q2 | - EUR | 0.0% |
2013 Q4 | -61.60 EUR | 100.0% |
2013 FY | - EUR | 4.72% |
2013 Q3 | -138.35 Million EUR | 0.0% |
2013 Q2 | -138.35 Million EUR | 0.0% |
2013 Q1 | -138.35 Million EUR | -433347.32% |
2012 FY | - EUR | 0.0% |
2012 Q1 | -145.2 Million EUR | 0.0% |
2012 Q2 | -145.2 Million EUR | 0.0% |
2012 Q3 | -145.2 Million EUR | 0.0% |
2012 Q4 | -31.92 Thousand EUR | 99.98% |
2011 Q4 | -145.2 Million EUR | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Crossject Société Anonyme | -0.23 EUR | 97.87% |
Spineway SA | -0.41 EUR | 98.805% |
Amplitude Surgical SA | 0.03 EUR | 115.361% |
Sartorius Stedim Biotech S.A. | 3.36 EUR | 100.146% |
EssilorLuxottica Société anonyme | 5.08 EUR | 100.096% |
bonyf N.V. | - EUR | Infinity% |